Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 0.6400
0.00 (0.00%)
Jun 30, 2026, 5:18 PM CET
Safe Orthopaedics Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.36 | 5.04 | 5.81 | 5.86 | 4.55 | |
Revenue Growth | 6.41% | -13.24% | -0.87% | 28.70% | 24.49% |
Cost of Revenue | 1.81 | 2.48 | 1.59 | 2.2 | 1.98 |
Gross Profit | 3.55 | 2.57 | 4.22 | 3.66 | 2.57 |
Selling, General & Admin | 6.29 | 7.8 | 7.66 | 8.87 | 9.27 |
Other Operating Expenses | 1.4 | 2.17 | -0.13 | -0.16 | 0.02 |
Operating Expenses | 7.89 | 10.77 | 10.41 | 9.62 | 10.16 |
Operating Income | -4.34 | -8.21 | -6.19 | -5.96 | -7.58 |
Interest Expense | -0.51 | - | -0.22 | -0.42 | -0.64 |
Interest & Investment Income | - | 0.49 | - | 0.21 | - |
Currency Exchange Gain (Loss) | - | - | 0.36 | -0.64 | 1.51 |
Other Non Operating Income (Expenses) | 0.08 | 259.64 | -263.48 | -0.15 | -0 |
EBT Excluding Unusual Items | -4.77 | 251.93 | -269.52 | -6.97 | -6.71 |
Impairment of Goodwill | - | - | -1.79 | - | - |
Asset Writedown | -0.01 | - | - | - | - |
Other Unusual Items | 0.08 | -2,116 | - | - | - |
Pretax Income | -4.71 | -1,864 | -271.32 | -6.97 | -6.71 |
Income Tax Expense | -0.03 | 65.21 | -65.87 | -0 | - |
Net Income | -4.67 | -1,929 | -205.44 | -6.97 | -6.71 |
Net Income to Common | -4.67 | -1,929 | -205.44 | -6.97 | -6.71 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | - | - | - | - |
Shares Outstanding (Diluted) | 0 | - | - | - | - |
Shares Change | - | - | - | - | - |
EPS (Basic) | -23.46 | - | - | - | - |
EPS (Diluted) | -23.46 | - | - | - | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.02 | -3.27 | 64.69 | -6.33 | -8.22 |
Free Cash Flow Per Share | -10.12 | - | - | - | - |
Gross Margin | 66.24% | 50.88% | 72.70% | 62.52% | 56.52% |
Operating Margin | -80.82% | -162.78% | -106.45% | -101.69% | -166.47% |
Profit Margin | -87.14% | -38272.62% | -3536.04% | -118.84% | -147.32% |
Free Cash Flow Margin | -37.60% | -64.91% | 1113.37% | -107.95% | -180.41% |
EBITDA | -3.82 | -7.42 | -3.66 | -5 | -6.72 |
EBITDA Margin | -71.25% | -147.25% | -62.93% | -85.33% | -147.45% |
D&A For EBITDA | 0.51 | 0.78 | 2.53 | 0.96 | 0.87 |
EBIT | -4.34 | -8.21 | -6.19 | -5.96 | -7.58 |
EBIT Margin | -80.82% | -162.78% | -106.45% | -101.69% | -166.47% |
Advertising Expenses | 0.01 | 0.02 | 0.04 | 0.11 | 0.07 |